Clinical Trial Update: Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) [Phase 3]

View source ↗

Summary

This clinical trial update reports on the safety and effectiveness of ciclesonide nasal spray for treating perennial allergic rhinitis in children aged 6 to 11 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Perennial Allergic Rhinitis, Allergic Rhinitis | Phase 3 | Status: COMPLETED